|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US7253264B1
(en)
*
|
1990-06-28 |
2007-08-07 |
Sanofi-Arentideutschland GmbH |
Immunoglobulin fusion proteins, their production and use
|
|
AU668349B2
(en)
|
1991-04-25 |
1996-05-02 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin 6 receptor
|
|
US5734014A
(en)
|
1992-08-11 |
1998-03-31 |
Tsumura & Co. |
Elafin derivative
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
TW575567B
(en)
*
|
1998-10-23 |
2004-02-11 |
Akzo Nobel Nv |
Serine protease inhibitor
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
JP2002537810A
(ja)
*
|
1999-03-01 |
2002-11-12 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
ヒトセルピンタンパク質
|
|
US6849605B1
(en)
*
|
1999-03-05 |
2005-02-01 |
The Trustees Of University Technology Corporation |
Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
|
|
EP1189931B1
(en)
|
1999-07-02 |
2006-06-21 |
Genentech, Inc. |
Peptide compounds that bind her2
|
|
JP2003515325A
(ja)
|
1999-12-01 |
2003-05-07 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
４ジスルフィドコアドメイン含有（ｆｄｃｄ）ポリヌクレオチド、ポリペプチド、および抗体
|
|
US6926898B2
(en)
*
|
2000-04-12 |
2005-08-09 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
FR2814957B1
(fr)
|
2000-10-06 |
2002-12-20 |
Aventis Pasteur |
Composition vaccinale et procede de stabilisation
|
|
WO2002038160A1
(en)
*
|
2000-11-08 |
2002-05-16 |
Prometic Biosciences Inc. |
Method for the treatment of inflammation
|
|
SI1724284T1
(sl)
|
2000-12-07 |
2009-12-31 |
Lilly Co Eli |
Glp-1 fuzijski proteini
|
|
EP1355919B1
(en)
*
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7247704B2
(en)
*
|
2000-12-18 |
2007-07-24 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
|
JP4426179B2
(ja)
*
|
2000-12-18 |
2010-03-03 |
アライバ ファーマシューティカルズ，インコーポレイティド |
多機能性プロテアーゼインヒビターおよびそれらの疾患治療における使用
|
|
US7211395B2
(en)
*
|
2001-03-09 |
2007-05-01 |
Dyax Corp. |
Serum albumin binding moieties
|
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
US6797493B2
(en)
|
2001-10-01 |
2004-09-28 |
Lee-Hwei K. Sun |
Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities
|
|
US20080194481A1
(en)
*
|
2001-12-21 |
2008-08-14 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US7217797B2
(en)
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
US7365168B2
(en)
|
2002-10-15 |
2008-04-29 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
EP1415664A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Switch Biotech Aktiengesellschaft |
Use of alpha 1-antichymotrypsin in combination with alpha-1-antitrypsin for treating/preventing diabetes associated or poorly healing arterial wounds
|
|
US7427595B1
(en)
*
|
2002-12-12 |
2008-09-23 |
Cornell Research Foundation, Inc. |
Use of proepithelin to promote wound repair and reduce inflammation
|
|
DE10303664A1
(de)
*
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
|
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
|
ATE385806T1
(de)
|
2003-06-12 |
2008-03-15 |
Lilly Co Eli |
Fusionsproteine
|
|
DK2520654T3
(en)
*
|
2003-08-26 |
2017-05-01 |
Univ Colorado Regents |
Inhibitors of serine protease activity and their use in methods and compositions for the treatment of bacterial infections
|
|
BRPI0406605B8
(pt)
*
|
2003-11-13 |
2021-05-25 |
Hanmi Holdings Co Ltd |
conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
US7914771B2
(en)
*
|
2004-03-09 |
2011-03-29 |
Arriva Pharmaceuticals, Inc. |
Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
|
|
WO2005100402A1
(en)
|
2004-04-13 |
2005-10-27 |
F.Hoffmann-La Roche Ag |
Anti-p-selectin antibodies
|
|
PL1751184T3
(pl)
|
2004-05-13 |
2010-02-26 |
Lilly Co Eli |
Białka fuzyjne FGF-21
|
|
ES2473587T3
(es)
|
2004-08-03 |
2014-07-07 |
Transtech Pharma, Inc. |
Proteínas de fusión de RAGE y métodos de uso
|
|
KR20070041781A
(ko)
|
2004-08-11 |
2007-04-19 |
트루비온 파마슈티칼스, 인코포레이티드 |
결합 도메인 융합 단백질
|
|
US7399746B2
(en)
|
2004-10-06 |
2008-07-15 |
Mcgill University |
Agents for wound healing
|
|
US9200079B2
(en)
|
2004-11-12 |
2015-12-01 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
JP5838021B2
(ja)
*
|
2005-04-15 |
2015-12-24 |
マクロジェニクス，インコーポレーテッド |
共有結合型ダイアボディとその使用
|
|
WO2006130834A2
(en)
*
|
2005-05-31 |
2006-12-07 |
Board Of Regents, The University Of Texas System |
IGGl ANTIBODIES WITH MUTATED FC PORTION FOR INCREASED BINDING TO FCRN RECEPTOR AND USES THEREOF
|
|
CN103665168A
(zh)
|
2005-06-03 |
2014-03-26 |
持田制药株式会社 |
抗cd14抗体融合蛋白质
|
|
NZ565511A
(en)
|
2005-07-22 |
2011-03-31 |
Five Prime Therapeutics Inc |
Compositions and methods of treating disease with FGFR fusion proteins
|
|
WO2007021807A1
(en)
|
2005-08-12 |
2007-02-22 |
Schering Corporation |
Mcp1 fusions
|
|
BRPI0618947B1
(pt)
*
|
2005-11-23 |
2022-07-19 |
Acceleron Pharma Inc |
Polipeptídeo actriia que se liga à ativina, polinucleotídeo isolado, polinucleotídeo recombinante, métodopara preparar um polipeptídeo actriia que se liga à ativina, preparação farmacêutica e uso de uma proteína de fusão actriia-fc para promover o crescimento ósseo e inibir a ressorção óssea
|
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
|
EP2012819A2
(en)
|
2006-03-30 |
2009-01-14 |
The Research Foundation Of the City university of New York |
Stimulation of neuron regeneration by secretory leukocyte protease inhibitor
|
|
GB0614780D0
(en)
*
|
2006-07-25 |
2006-09-06 |
Ucb Sa |
Biological products
|
|
KR20090058532A
(ko)
*
|
2006-08-28 |
2009-06-09 |
아레스 트레이딩 에스.에이. |
Ｆｃ융합 단백질을 정제하는 방법
|
|
WO2008138017A2
(en)
|
2007-05-08 |
2008-11-13 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for modifying t cell immune responses and inflammation
|
|
CN101687933B
(zh)
*
|
2007-05-30 |
2015-11-25 |
浦项工科大学校产学协力团 |
免疫球蛋白融合蛋白
|
|
CA2688434A1
(en)
*
|
2007-06-06 |
2008-12-11 |
Domantis Limited |
Polypeptides, antibody variable domains and antagonists
|
|
WO2009045508A1
(en)
*
|
2007-10-02 |
2009-04-09 |
Research Foundation Of City University Of New York |
Novel protein transduction domains derived from secretory leukocyte protease inhibitor
|
|
AR064713A1
(es)
|
2007-12-28 |
2009-04-22 |
Consejo Nac Invest Cient Tec |
Proteina de fusion que se une a transglutaminasas , composiciones que la comprenden , micro- esferas que la comprenden, usos y metodos
|
|
WO2009158432A2
(en)
|
2008-06-27 |
2009-12-30 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
|
EP2300501B1
(en)
*
|
2008-07-23 |
2014-08-20 |
Hanmi Science Co., Ltd. |
A polypeptide complex comprising non-peptidyl polymer having three functional ends
|
|
CN102171343B
(zh)
|
2008-08-04 |
2017-07-14 |
戊瑞治疗有限公司 |
Fgfr细胞外结构域酸性区突变蛋白
|
|
JP5734201B2
(ja)
|
2008-12-19 |
2015-06-17 |
マクロジェニクス，インコーポレーテッド |
共有結合型ダイアボディ及びその使用
|
|
MX2011010681A
(es)
|
2009-04-10 |
2012-01-20 |
Ablynx Nv |
Secuencias mejoradas de aminoacidos dirigidas contra il-6r y polipeptidos que comprenden el mismo para el tratamiento de enfermedades y trastornos relacionados con il-6r.
|
|
CN102439044B
(zh)
|
2009-04-22 |
2014-08-13 |
阿特根公司 |
通过体内持续释放维持的体内半衰期增加的融合蛋白质或融合肽以及使用所述融合蛋白质或融合肽增加体内半衰期的方法
|
|
SE533763C2
(sv)
|
2009-05-04 |
2010-12-28 |
Lars Hammar |
Upphängningsanordning
|
|
CN105557503A
(zh)
|
2009-07-08 |
2016-05-11 |
密苏里大学管委会 |
利用传统大豆育种技术培育高油酸大豆的方法
|
|
PT2498799T
(pt)
|
2009-11-13 |
2016-11-04 |
Five Prime Therapeutics Inc |
Utilização de proteínas do domínio extracelular rfcf1 para tratar cancros caracterizados por mutações ativadoras dependentes de ligando em rfcf2
|
|
GB201003559D0
(en)
|
2010-03-03 |
2010-04-21 |
Proteo Biotech Ag |
Novel use of elafin
|
|
EP2588140A4
(en)
|
2010-06-30 |
2015-07-15 |
Univ Maryland |
DENTAL COMPOUNDS WITH NANOPARTICLES OF AMORPHIC CALCIUM PHOSPHATE
|
|
SG191233A1
(en)
|
2010-12-23 |
2013-07-31 |
Janssen Biotech Inc |
Active protease-resistant antibody fc mutants
|
|
LT2691417T
(lt)
|
2011-03-29 |
2018-10-25 |
Roche Glycart Ag |
Antikūno fc variantai
|
|
EP3628327A1
(en)
*
|
2011-06-24 |
2020-04-01 |
The Regents of the University of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
EP2537864B1
(en)
|
2011-06-24 |
2019-08-07 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Fc variants with reduced effector functions
|
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
|
RU2639526C2
(ru)
|
2011-06-28 |
2017-12-21 |
ИНХИБРКС ЭлЭлСи |
Слитые полипептиды, содержащие домен wap, и способы их применения
|
|
SMT201900520T1
(it)
|
2011-06-28 |
2019-11-13 |
Inhibrx Lp |
Polipeptidi di fusione serpinici e relativi metodi d'uso
|
|
EA026226B1
(ru)
*
|
2011-07-01 |
2017-03-31 |
Байоджен Айдек Ма Инк. |
Не содержащие аргинина композиции слитого fc-полипептида и способы их применения
|
|
KR20140137347A
(ko)
|
2012-01-10 |
2014-12-02 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
|
MX2014015557A
(es)
|
2012-06-21 |
2015-02-24 |
Univ Indiana Res & Tech Corp |
Polipeptidos de fusion de region fc de polipeptido de ligando receptor de incretina y conjugados con función efectora fc alterada.
|
|
KR20150030744A
(ko)
|
2012-06-27 |
2015-03-20 |
에프. 호프만-라 로슈 아게 |
표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Ｆｃ－영역 접합체의 제조 방법 및 그의 용도
|
|
CA2876096A1
(en)
|
2012-08-02 |
2014-02-06 |
Petra Rueger |
Method for producing soluble fcr as fc-fusion with inert immunoglobulin fc-region and uses thereof
|
|
EP2929045B1
(en)
|
2012-12-05 |
2020-12-02 |
SOLA Biosciences LLC |
Protein expression enhancing polypeptides
|
|
CN203917563U
(zh)
|
2014-03-27 |
2014-11-05 |
陈广煌 |
一种切角模具
|
|
US20170190762A1
(en)
*
|
2014-06-11 |
2017-07-06 |
Beth Israel Deaconess Medical Center, Inc. |
Alpha1 -antitrypsin compositions and methods of treating autoimmune diseases
|